what are glp 1's GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 Medications – Community Education
Description
This is most graphically demonstrated in the UKPDS (65) and A Diabetes Outcome Progression Trial (ADOPT) (5) (Fig
doi: 10.1016/j.cmet.2012.06.015
Assets Download Contact Jen Treadwell [email protected] 1
Yabut and Daniel J
While some of the trials reported a decrease in appetite as a side effect, like the ADJUNCT trials (5358, 60), it should be noted that this is one of the main mechanisms of action of these drugs to achieve weight loss
